Pediatric recommendations for preventing and controlling Candida auris released

by Lindsay MacMurray, Society for Healthcare Epidemiology of America

edited by Gaby Clark, reviewed by Andrew Zinin

Gaby Clark

Scientific Editor

Meet our editorial team
Behind our editorial process

Andrew Zinin

Chief Editor

Meet our editorial team
Behind our editorial process Editors' notes

This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:

fact-checked

trusted source

proofread

The GIST Add as preferred source

The Society for Healthcare Epidemiology of America (SHEA) has released a new consensus statement providing pediatric-specific recommendations for the infection prevention and control of Candida auris (also referred to as Candidozyma auris), a multidrug-resistant fungal pathogen associated with health care-associated infections and outbreaks worldwide. The research is published in the journal Antimicrobial Stewardship & Healthcare Epidemiology.

Existing recommendations for detecting and preventing C. auris have primarily focused on adult populations in acute and long-term health care facilities. SHEA's new consensus statement addresses high-priority gaps for pediatric and child-serving settings, including neonatal intensive care units, pediatric hospitals and units, long-term care and rehabilitation facilities for children, schools, child care settings and family residential facilities.

The recommendations emphasize practical strategies for health care personnel, caregivers, families, infection prevention teams and public health partners. They address pediatric realities that differ from adult care, including caregiver rooming-in, breastfeeding and skin-to-skin practices, shared play and therapy spaces, specialized pediatric equipment, toys, breast pumps and communication needs across health care and non-health care settings.

"Children receive care in environments that look very different from adult health care settings, and infection prevention guidance must account for the essential role of caregivers and families," said Lisa Maragakis, MD, MPH, president of SHEA. "These recommendations are designed to help teams reduce transmission risk while supporting family-centered pediatric care."

Key recommendations include providing plain-language education for caregivers and visitors, coordinating with local infection prevention and public health partners, using targeted screening based on defined exposures, maintaining rigorous environmental cleaning and disinfection with products effective against C. auris, and supporting thoughtful disclosure practices to avoid stigma or unnecessary exclusion of children in non-health care congregate settings.

The consensus statement also recognizes the importance of family-centered care. It supports caregiver presence, including rooming-in, and encourages breastfeeding and skin-to-skin practices where appropriate, using shared decision-making when evidence is limited or patient-specific risks require individualized planning.

"Because C. auris remains relatively rare in pediatrics, clear communication and coordinated implementation are essential," said first author Thomas Murray, MD, Ph.D. "The guidance gives clinicians and child-serving facilities a framework for practical, setting-specific decisions."

The consensus statement was developed by a multidisciplinary expert panel with subject-matter experts in pediatric infectious diseases, infection prevention and control, neonatology, early childhood care and education, long-term care, and family partnership.

More information

Thomas S. Murray et al, Infection prevention and control of Candida auris in pediatric settings, Antimicrobial Stewardship & Healthcare Epidemiology (2026). DOI: 10.1017/ash.2026.10419

Key medical concepts

Candida aurisInfection ControlIntensive Care Units, NeonatalLong-Term Care Facility

Clinical categories

PediatricsInfectious diseasesChildren's healthCommon illnesses & Prevention Provided by Society for Healthcare Epidemiology of America Who's behind this story?

Gaby Clark

MA in English, copy editor since 2021 with experience in higher education and health content. Dedicated to trustworthy science news. Full profile →

Andrew Zinin

Master's in physics with research experience. Long-time science news enthusiast. Plays key role in Science X's editorial success. Full profile →

Citation: Pediatric recommendations for preventing and controlling Candida auris released (2026, June 24) retrieved 24 June 2026 from https://medicalxpress.com/news/2026-06-pediatric-candida-auris.html This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.